New Naphtho[2,3-B]Furan Derivatives
AssigneeBoston Biomedical, Inc.
InventorsHitoshi Ban, Seiji Kamioka, Manabu Kusagi
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoston Biomedical, Inc.
InventorsHitoshi Ban, Seiji Kamioka, Manabu Kusagi
Estimating the term…
The present invention provides a compound useful as a novel antitumor agent targeting a CSC that is important in continuous proliferation of malignant tumor, metastasis and recurrence of cancer, and its resistance to an antitumor agent; a medicament comprising the compound as an active ingredient; a pharmaceutical composition; and an antitumor agent; as well as a method of treating cancer and/or a method of preventing cancer. The present invention provides compounds represented by formula (I): or pharmaceutically acceptable salts thereof, wherein X is an oxygen atom or sulfur atom; R1 is a hydrogen atom, an alkyl group, or the like; R2 is a halogen atom or the like; R3 is a hydrogen atom, an alkyl group, or the like; m is 0, 1, 2, 3, or 4; and n is 1, 2, 3, or 4 (with the proviso that the sum of m and n is 1, 2, 3, or 4).
A compound represented by formula (I):
Dependencies are inferred from the claim text.